Therapeutic Plasma Exchange Industry Growth Expected to Reach $2.32 Billion by 2029 at a CAGR of 9.5% | Segmentation and Growth Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Therapeutic Plasma Exchange Market Growth Performance Trended Historically, And What Lies Ahead?_x000D_
There has been a substantial growth in the therapeutic plasma exchange market in the previous years. The market is projected to expand from a value of $1.47 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. Factors contributing to the growth during the historic period include the rise of immunological diseases, advancements in technology, increased knowledge and awareness, broader indications, and enhanced comprehension of the pathophysiology._x000D_
_x000D_
#What Is the Forecast for the Therapeutic Plasma Exchange Market Size Through 2029?#_x000D_
The size of the therapeutic plasma exchange market is anticipated to experience robust growth in the upcoming years. It is projected to expand to $2.32 billion by 2029, with a compound annual growth rate (CAGR) of 9.5%. The expansion during the forecast period can be ascribed to factors such as the growing elderly population, clinical proof and guidelines, regulatory matters, developments in hospital infrastructure and healthcare investments, healthcare spending, and reimbursement policies. Key trends during the forecast period will be the adoption of personalized treatments, the inclusion of automation, cooperation initiatives, and the integration of telemedicine._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp_x000D_
_x000D_
#What are the Key Market Players in Therapeutic Plasma Exchange Market and How They’re Evolving?#_x000D_
Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd._x000D_
_x000D_
#What Are the Primary Growth Drivers in the Therapeutic Plasma Exchange Market?#_x000D_
The therapeutic plasma exchange market is expected to experience accelerated growth due to an increase in hematological disorders. These blood-related disorders, also known as blood diseases, impact the blood and tissues that produce blood, such as lymph nodes, the spleen, and bone marrow. The rise in hematological disorders can be attributed to factors such as genetic predisposition, environmental factors, and lifestyle modifications. Therapeutic plasma exchange plays a crucial role in these diseases by eliminating harmful substances, like autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, from the plasma. This leads to decreased disease severity and enhanced patient health outcomes. For example, the Leukemia and Lymphoma Society in the US projected in August 2023 that myeloma diagnoses are anticipated to increase by approximately 2.3% from 2021 to 2023, escalating the number from 34,920 to 35,730. Hence, the rise in hematological disorders contributes to driving the expansion of the therapeutic plasma exchange market._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=15683&type=smp_x000D_
_x000D_
#What Are the Leading Segments in the Global Therapeutic Plasma Exchange Industry?#_x000D_
The therapeutic plasma exchange market covered in this report is segmented –_x000D_
_x000D_
1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)_x000D_
2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications_x000D_
3) By Technology: Centrifugation, Membrane Separation_x000D_
4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe, Automated Tpe_x000D_
2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp, Multi-Stage Dfpp_x000D_
_x000D_
#What Are the Key Market Trends in the Therapeutic Plasma Exchange Industry?#_x000D_
The primary participants in the therapeutic plasma exchange market are employing a strategic alliance strategy to facilitate the integration of technology and broaden their market footprint. A strategic alliance is typically a form of cooperation that brings together two or more entities, channelizing their resources, knowledge, and efforts in pursuing shared goals or objectives. For example, in July 2022, Terumo Blood and Cell Technologies, a U.S. technological firm, joined forces with Eliaz Therapeutics Inc., a U.S. medical equipment manufacturer specialised in therapeutic apheresis for inflammatory and renal conditions. The partnership focuses on the treatment of acute kidney injury (AKI) and sepsis-induced AKI (S-AKI) by selectively eliminating the Gal-3 inflammatory protein from blood plasma. Given the high mortality rates linked to AKI, the purpose of this collaboration is to investigate innovative treatments using Terumo’s Spectra Optia Apheresis System combined with ETI’s XGal-3 column. The preliminary research will be conducted on larger animals before shifting to human clinical trials. Terumo, renowned for its inventive approach to therapeutic apheresis, has previously collaborated on projects aimed at conditions like triple-negative breast cancer and COVID-19._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
_x000D_
#What Is the Regional Outlook for the Therapeutic Plasma Exchange Market?#_x000D_
North America was the largest region in the therapeutic plasma exchange market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15683_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the therapeutic plasma exchange market, and how is it changing globally?_x000D_
2. Who are the major companies in the therapeutic plasma exchange market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the therapeutic plasma exchange market right now?_x000D_
4. Which products or customer segments are growing the most in the therapeutic plasma exchange market?_x000D_
5. What factors are helping or slowing down the growth of the therapeutic plasma exchange market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 2071930708_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
